$14.89
00.00%
Pre-Market: 7:00 AM EDT
15 minutes delayed
NovoCure reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NovoCure using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-25 | $-0.31 | $-0.41 | 24.4 % |
Mar 2024 | 2024-05-02 | $-0.36 | $-0.42 | 14.3 % |
Dec 2023 | 2024-02-22 | $-0.45 | $-0.52 | 13.5 % |
Sep 2023 | 2023-10-26 | $-0.46 | $-0.52 | 11.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-25 | $150.36M | $135.82M | 10.7 % |
Mar 2024 | 2024-05-02 | $138.50M | $131.45M | 5.37 % |
Dec 2023 | 2024-02-22 | $133.78M | $131.19M | 1.98 % |
Sep 2023 | 2023-10-26 | $127.32M | $128.76M | -1.12 % |
NovoCure (NVCR) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on July 25, 2024 for Q2.
The Actual EPS was $-0.31, which beat the estimate of $-0.41.
The Actual Revenue was $150.4M, which beat the estimate of $135.8M.
Browse earnings estimates, EPS, and revenue on all stocks.